{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:45:53Z","timestamp":1659091553184},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Natl Compr Canc Netw"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.6004\/jnccn.2012.0010","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T16:00:41Z","timestamp":1492185641000},"page":"112-118","source":"Crossref","is-referenced-by-count":1,"title":["How to Choose Frontline Therapy for Chronic Myelogenous Leukemia: So Many Drugs, Not So Many Patients"],"prefix":"10.6004","volume":"10","author":[{"given":"Paul J.","family":"Shami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","published-online":{"date-parts":[[2012,1,5]]},"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:07:57Z","timestamp":1551719277000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/doi\/10.6004\/jnccn.2012.0010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,5]]},"published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.6004\/jnccn.2012.0010"],"URL":"https:\/\/doi.org\/10.6004\/jnccn.2012.0010","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}